Know Cancer

forgot password

Physical Activity and Inactivity in Lung Cancer Survivors

Open (Enrolling)
Lung Cancer Survivors

Thank you

Trial Information

Physical Activity and Inactivity in Lung Cancer Survivors

Despite the potential benefits of physical activity, particularly for cancer survivors with
comorbid pulmonary and cardiac conditions, no previous research has examined the physical
activity levels of lung cancer survivors, an underrepresented subpopulation in cancer
survivorship research. We address this research gap in the current study, in which a random
sample of 200 lung cancer survivors will complete a comprehensive telephone interview or use
self-report to complete a questionnaire focusing on physical activity, related covariates,
and preferences regarding physical activity counseling and interventions. We estimate the
total time for the completion of the interview or self-report questionnaire to be 45-60
minutes. This study will be conducted with survivors of primary lung cancer who are from 1
to 5 years posttreatment and were treated at Memorial Sloan-Kettering Cancer Center (MSKCC).

Inclusion Criteria:

- Diagnosis of primary Stage IA or IB NSCLC;

- Underwent surgical resection for NSCLC at MSKCC;

- From 1 to 5 years post-treatment for NSCLC prior to study recruitment;

- No evidence of disease (NED) at the time of recruitment;

- Can be reached by telephone;

- Able to provide informed consent.

Exclusion Criteria:

- Undergoing active antineoplastic treatment;

- Major psychopathology or cognitive impairment likely in the judgment of the
investigator to interfere with participation and compliance with the protocol.

Type of Study:


Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Outcome Measure:

The primary outcomes of this study are physical activity levels and preferences regarding physical activity counseling and interventions

Outcome Time Frame:

45-60 minutes

Safety Issue:


Principal Investigator

Jamie Ostroff, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center


United States: Food and Drug Administration

Study ID:




Start Date:

September 2005

Completion Date:

September 2013

Related Keywords:

  • Lung Cancer Survivors
  • Lung Cancer
  • Survivor
  • Lung
  • Lung Neoplasms



Memorial Sloan-Kettering Cancer Center New York, New York  10021